Royal Bank of Canada’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.11M | Buy |
|
|||||
|
2025
Q2 | $365K | Buy |
|
|||||
|
2025
Q1 | $209K | Sell |
|
|||||
|
2024
Q4 | $2.93M | Buy |
|
|||||
|
2024
Q3 | $3.67M | Buy |
|
|||||
|
2024
Q2 | $191K | Sell |
|
|||||
|
2024
Q1 | $317K | Sell |
|
|||||
|
2023
Q4 | $1.59M | Sell |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $2.62M | Sell |
|
|||||
|
2023
Q1 | $2.28M | Buy |
|
|||||
|
2022
Q4 | $197K | Buy |
|
|||||
|
2022
Q3 | $155K | Sell |
|
|||||
|
2022
Q2 | $410K | Sell |
|
|||||
|
2022
Q1 | $526K | Sell |
|
|||||
|
2021
Q4 | $734K | Buy |
|
|||||
|
2021
Q3 | $719K | Sell |
|
|||||
|
2021
Q2 | $3.05M | Buy |
|
|||||
|
2021
Q1 | $727K | Buy |
|
|||||
|
2020
Q4 | $686K | Buy |
|
|||||
|
2020
Q3 | $194K | Buy |
|
|||||
|
2020
Q2 | $95K | Buy |
|
|||||
|
2020
Q1 | $8K | Sell |
|
|||||
|
2019
Q4 | $107K | Buy |
|
|||||
|
2019
Q3 | $65K | Buy |
|
|||||
|
2019
Q2 | $12K | Sell |
|
|||||
|
2019
Q1 | $85K | Buy |
|
|||||
|
2018
Q4 | $42K | Sell |
|
|||||
|
2018
Q3 | $172K | Buy |
|
|||||
|
2018
Q2 | $155K | Buy |
|
|||||
|
2018
Q1 | $16K | Sell |
|
|||||
|
2017
Q4 | $12.6M | Buy |
|
|||||
|
2017
Q3 | $12.3M | Buy |
|
|||||
|
2017
Q2 | $13.9M | Buy |
|
|||||
|
2017
Q1 | $1.47M | Sell |
|
|||||
|
2016
Q4 | $10.9M | Sell |
|
|||||
|
2016
Q3 | $11.5M | Buy |
|
|||||
|
2016
Q2 | $6.53M | Buy |
|
|||||
|
2016
Q1 | $7.31M | Buy |
|
|||||
|
2015
Q4 | $4K | Sell |
|
|||||
|
2015
Q3 | $173K | Sell |
|
|||||
|
2015
Q2 | $430K | Sell |
|
|||||
|
2015
Q1 | $702K | Buy |
|